MAKINDO MEDICINEClinical textbook for medical students and doctors
For education and revision only. Not individual medical advice; check current NICE/BNF and local guidance before clinical use. Clinical safety and terms.
Chapter 211 of 268
Images
MAKINDO MEDICINE · Physiology211 / 268

Physiology: Cells, tissues, homeostasis, fluids and acid–base balance

Expanded anatomy and physiology — detailed original material incorporated in this chapter: Cellular physiology, tissues and homeostasis

⚗️ Body fluids, electrolytes and acid–base balance. Fluid and electrolyte problems are among the commonest abnormalities in hospital and the most frequently examined physiology in the UKMLA and MRCP. Understanding the physiology - where water and solutes are, how the kidney handles them, and how pH is defended - turns blood results into diagnoses. This chapter covers fluid compartments, sodium and water, potassium, calcium and phosphate, magnesium, and acid–base physiology with a systematic approach to blood gases.
Your four questions for any electrolyte or gas result: Which compartment has gained or lost water or solute? Is the problem intake, shift between compartments, or loss (kidney, gut, skin)? Is the body compensating appropriately? How fast did it develop, and how fast is it safe to correct?


Body Fluid Compartments
  • Total body water (TBW) - about 60% of body weight in adult men, 50–55% in women and older people (more fat), 75% in neonates. A 70 kg man has about 42 L.
  • Intracellular fluid (ICF) - two-thirds of TBW (about 28 L).
  • Extracellular fluid (ECF) - one-third (about 14 L): interstitial fluid (three-quarters, about 10–11 L) and plasma (one-quarter, about 3–3.5 L); plus small transcellular volumes (CSF, synovial, ocular, GI secretions).
  • Blood volume - about 70 mL/kg (5 L in adults); 80–90 mL/kg in children.
IonECF (mmol/L)ICF (mmol/L)
Na⁺135–14510–15
K⁺3.5–5.0140–150
Cl⁻100–1105–10
HCO₃⁻22–2910
Proteins and phosphatesLowHigh (major ICF anions)
  • Na⁺/K⁺-ATPase (3 Na⁺ out, 2 K⁺ in) maintains the gradients and consumes a large share of resting energy.
  • Distribution of IV fluids: 1 L of 5% glucose distributes across TBW (only about 80 mL stays in plasma); 1 L of 0.9% saline or Hartmann's distributes across the ECF (about 250 mL stays in plasma); colloids initially stay mainly intravascular.
Starling Forces and Oedema
  • Net filtration across capillaries = Kf [(Pc − Pi) − σ(πc − πi)] - hydrostatic pressure pushes fluid out; plasma oncotic pressure (mainly albumin) pulls it in.
  • The revised Starling principle - the endothelial glycocalyx is the key barrier; most filtered fluid returns via lymphatics rather than venous reabsorption.
  • Oedema mechanisms:
    • Raised capillary hydrostatic pressure - heart failure, venous obstruction (DVT), fluid overload, CCBs (arteriolar dilatation).
    • Reduced plasma oncotic pressure - hypoalbuminaemia (nephrotic syndrome, liver failure, malnutrition, protein-losing enteropathy).
    • Increased capillary permeability - sepsis, burns, inflammation, anaphylaxis.
    • Lymphatic obstruction - lymphoedema (non-pitting with time) after surgery, radiotherapy, filariasis, malignancy.
  • Pitting oedema - mobile interstitial fluid; non-pitting - lymphoedema, myxoedema, lipoedema.
Osmolality, Tonicity and Water Balance
  • Plasma osmolality normally 275–295 mOsm/kg. Calculated osmolality = 2[Na⁺] + [glucose] + [urea] (all in mmol/L).
  • Osmolar gap = measured − calculated osmolality; normal <10. A raised gap suggests unmeasured osmoles: ethanol, methanol, ethylene glycol, mannitol, sorbitol.
  • Tonicity (effective osmolality) - only solutes that do not cross membranes freely (Na⁺, glucose) move water; urea crosses membranes and is an "ineffective" osmole.
  • Water balance: intake (thirst) and ADH (vasopressin). Hypothalamic osmoreceptors detect a 1–2% rise in osmolality → ADH release from the posterior pituitary → aquaporin-2 insertion in the collecting duct → concentrated urine (up to about 1,200 mOsm/kg). ADH is also released by large falls in blood volume (baroreceptors), nausea, pain and drugs.
  • Daily requirements (NICE CG174, adults): water 25–30 mL/kg/day; Na⁺, K⁺ and Cl⁻ about 1 mmol/kg/day each; glucose 50–100 g/day to limit starvation ketosis.
  • Diabetes insipidus - central (lack of ADH) or nephrogenic (renal resistance - lithium, hypercalcaemia, hypokalaemia); dilute urine with high plasma osmolality; water deprivation test with desmopressin to distinguish them.
Sodium and Volume Regulation
  • Total body sodium determines ECF volume; water balance determines sodium concentration.
  • Renal handling: proximal tubule (about 65% - NHE3, co-transporters; target of SGLT2 inhibitors and acetazolamide), thick ascending limb (about 25% - NKCC2, loop diuretics), distal convoluted tubule (about 5% - NCC, thiazides), collecting duct (2–3% - ENaC, aldosterone; amiloride, spironolactone).
  • Volume sensors: baroreceptors (carotid sinus, aortic arch, atria), renal afferent arteriole (renin release), macula densa (NaCl delivery).
  • Effectors: renin–angiotensin–aldosterone system, sympathetic nervous system, natriuretic peptides (ANP, BNP - natriuresis), ADH (non-osmotic release in hypovolaemia).
  • Hyponatraemia - mostly water excess with ADH active: classify by tonicity and volume status, then urine osmolality and sodium (see the Sodium Physiology topic and the Endocrinology chapter). SIADH - euvolaemic, hypotonic, urine osmolality >100 and urine Na >30 with normal thyroid and adrenal function.
  • Hypernatraemia - water deficit (impaired thirst or access - older people, infants), diabetes insipidus, osmotic diuresis.
  • Correction speed: chronic hyponatraemia - limit the rise to 10 mmol/L in 24 hours (8 if high risk) to avoid osmotic demyelination; hypernatraemia - lower gradually (about 10 mmol/L/day) to avoid cerebral oedema.
Potassium Physiology
  • 98% of potassium is intracellular; the K⁺ gradient sets the resting membrane potential (about −90 mV in myocytes).
  • Internal balance (shifts): insulin, β₂-agonists and alkalosis drive K⁺ into cells; acidosis (especially mineral acid), hyperosmolality, cell lysis, β-blockers and digoxin toxicity cause K⁺ to move out.
  • External balance: the kidney excretes about 90% of intake; secretion in the collecting duct via ROMK channels depends on aldosterone, distal Na⁺ delivery and flow.
  • Hyperkalaemia causes: AKI/CKD, drugs (ACEi, ARBs, spironolactone, trimethoprim, NSAIDs, heparin), hypoaldosteronism (Addison's, type 4 RTA), rhabdomyolysis, tumour lysis, haemolysed sample (pseudohyperkalaemia).
  • ECG changes in hyperkalaemia: tall tented T waves → loss of P waves, PR prolongation → broad QRS → sine wave → VF/asystole.
  • Hypokalaemia causes: diuretics (loop, thiazide), GI losses (diarrhoea, vomiting - via secondary hyperaldosteronism), hyperaldosteronism (Conn's), Cushing's, refeeding, insulin, β₂-agonists, hypomagnesaemia (makes it resistant to correction), renal tubular acidosis (types 1 and 2), Bartter's and Gitelman's syndromes.
  • ECG in hypokalaemia: flat or inverted T waves, U waves, ST depression, prolonged QT; increased digoxin toxicity.
  • Treatment principles: hyperkalaemia - protect the myocardium (IV calcium), shift (insulin–glucose, salbutamol), remove (binders, dialysis); hypokalaemia - oral or IV replacement (IV no faster than 10 mmol/hour peripherally outside critical care), correct magnesium.
Calcium, Phosphate and Vitamin D
  • Plasma calcium 2.2–2.6 mmol/L: about 45% ionised (active), 45% protein-bound (albumin), 10% complexed. Adjusted calcium = total Ca + 0.02 × (40 − albumin) (local formulae vary). Alkalosis increases albumin binding → lower ionised calcium → tetany (hyperventilation).
  • Parathyroid hormone (PTH) - released when ionised calcium falls (calcium-sensing receptor): increases bone resorption, increases renal calcium reabsorption (distal tubule) and phosphate excretion, stimulates 1α-hydroxylase in the kidney.
  • Vitamin D: skin (UVB) or diet → 25-hydroxylation in the liver (25(OH)D - the storage form measured to assess status) → 1α-hydroxylation in the kidney (1,25(OH)₂D, calcitriol - active) → increases gut absorption of calcium and phosphate.
  • Calcitonin (thyroid C cells) lowers calcium - minor physiological role in humans; a tumour marker for medullary thyroid cancer.
  • FGF-23 (from bone) increases phosphate excretion and suppresses calcitriol; raised in CKD.
PatternCaPO₄PTHCause
Primary hyperparathyroidism↑↓↑ or inappropriately normalParathyroid adenoma
Malignancy↑↓ or normal↓ (suppressed)PTHrP, bone metastases, myeloma
Secondary hyperparathyroidism (CKD)↓ or normal↑↑Phosphate retention, low calcitriol
Vitamin D deficiency↓ or normal↓↑Osteomalacia
Hypoparathyroidism↓↑↓Post-thyroidectomy, autoimmune
Pseudohypoparathyroidism↓↑↑PTH resistance
  • Hypercalcaemia symptoms: "bones, stones, groans and psychic moans" - bone pain, renal stones, polyuria and dehydration, abdominal pain, constipation, pancreatitis, confusion, short QT.
  • Hypocalcaemia signs: perioral and peripheral paraesthesia, carpopedal spasm, Trousseau's sign (carpal spasm with a BP cuff), Chvostek's sign (facial twitch on tapping the facial nerve), seizures, prolonged QT.
Magnesium
  • Normal plasma magnesium about 0.7–1.0 mmol/L; mostly intracellular and in bone.
  • Hypomagnesaemia causes: PPIs (long-term), diuretics, diarrhoea, alcohol excess, refeeding syndrome, aminoglycosides, ciclosporin, cisplatin.
  • Effects: impairs PTH secretion and action → refractory hypocalcaemia; renal K⁺ wasting → refractory hypokalaemia; arrhythmias (torsades de pointes), seizures, tremor.
  • Treatment: oral or IV magnesium sulfate; IV magnesium is also used in torsades de pointes, severe asthma and eclampsia.
pH, Buffers and the Henderson–Hasselbalch Equation
  • Normal arterial pH 7.35–7.45 ([H⁺] 35–45 nmol/L); PaCO₂ 4.7–6.0 kPa; HCO₃⁻ 22–29 mmol/L; base excess −2 to +2.
  • Henderson–Hasselbalch: pH = 6.1 + log ([HCO₃⁻] ÷ (0.23 × PaCO₂ in kPa)) - pH depends on the ratio of bicarbonate (kidney-controlled) to CO₂ (lung-controlled).
  • Buffers: the bicarbonate–carbonic acid system (the most important extracellular buffer - open system, because CO₂ is exhaled), haemoglobin (major intracellular buffer in red cells), phosphate (urine and intracellular), proteins.
  • Daily acid load: about 15,000 mmol of CO₂ (volatile acid, excreted by the lungs) and about 1 mmol/kg/day of non-volatile (fixed) acid (sulphuric and phosphoric acids from protein metabolism) excreted by the kidney.
  • Renal acid handling: reabsorption of filtered bicarbonate (proximal tubule, via carbonic anhydrase), generation of new bicarbonate by excretion of H⁺ as titratable acid (phosphate) and ammonium (NH₄⁺ - the main adaptive response to acidosis).
Respiratory and Renal Compensation
  • Respiratory compensation (for metabolic disorders) is fast (minutes to hours): metabolic acidosis → hyperventilation (Kussmaul breathing) → ↓PaCO₂.
  • Winter's formula - expected PaCO₂ in metabolic acidosis (in kPa) = 0.2 × HCO₃⁻ + 1.1 (± 0.25); in mmHg: 1.5 × HCO₃⁻ + 8 (± 2). If PaCO₂ is higher than expected, there is a coexisting respiratory acidosis.
  • Renal (metabolic) compensation for respiratory disorders is slow (3–5 days): chronic CO₂ retention (COPD) → raised bicarbonate.
  • Compensation never overcorrects - if pH is normal with abnormal CO₂ and HCO₃⁻, suspect a mixed disorder.
  • Rules of thumb: in acute respiratory acidosis, HCO₃⁻ rises by about 1 mmol/L per 1.3 kPa rise in PaCO₂; in chronic, by about 3–4 mmol/L per 1.3 kPa.
Interpreting a Blood Gas - Systematic Approach
  • Oxygenation: PaO₂ (normal 11–13 kPa on air). Compare with the inspired oxygen - expected PaO₂ ≈ FiO₂ (%) − 10 kPa; a large difference indicates impaired gas exchange (or calculate the A–a gradient). Type 1 respiratory failure - PaO₂ <8 kPa with normal or low PaCO₂; type 2 - PaO₂ <8 kPa with PaCO₂ >6.0 kPa.
  • pH: acidaemia (<7.35) or alkalaemia (>7.45).
  • Primary process: PaCO₂ moving in the opposite direction to pH → respiratory; HCO₃⁻ (or base excess) moving in the same direction as pH → metabolic.
  • Compensation: appropriate? (Winter's formula etc.)
  • If metabolic acidosis: calculate the anion gap.
  • Other values: lactate, glucose, K⁺, Na⁺, Cl⁻, Hb, COHb (carbon monoxide), MetHb.
DisorderpHPaCO₂HCO₃⁻Common causes
Respiratory acidosis↓↑↑ (if chronic)COPD, hypoventilation (opioids, neuromuscular weakness, obesity)
Respiratory alkalosis↑↓↓ (if chronic)Anxiety, PE, early sepsis, salicylate (early), pregnancy, altitude
Metabolic acidosis↓↓ (compensation)↓DKA, lactic acidosis, AKI, diarrhoea, RTA
Metabolic alkalosis↑↑ (compensation)↑Vomiting, diuretics, hypokalaemia, Conn's, Cushing's, milk–alkali
Anion Gap and Mixed Disorders
  • Anion gap = [Na⁺] − ([Cl⁻] + [HCO₃⁻]); normal about 8–12 mmol/L (if K⁺ is included, 10–16). Correct for low albumin (each 10 g/L fall in albumin lowers the gap by about 2.5).
  • Raised anion gap metabolic acidosis (unmeasured acids) - MUDPILES: Methanol, Uraemia, DKA (and alcoholic/starvation ketoacidosis), Paraldehyde/propylene glycol, Iron/isoniazid, Lactic acidosis, Ethylene glycol, Salicylates (also pyroglutamic acidosis with paracetamol in malnourished patients).
  • Normal anion gap (hyperchloraemic) metabolic acidosis - loss of bicarbonate or failure of acid excretion: diarrhoea, ileostomy, ureterosigmoidostomy, renal tubular acidosis, acetazolamide, Addison's disease, excess 0.9% saline.
  • Renal tubular acidosis: type 1 (distal - cannot excrete H⁺; urine pH >5.5; hypokalaemia; stones), type 2 (proximal - bicarbonate wasting; Fanconi syndrome; hypokalaemia), type 4 (hypoaldosteronism - hyperkalaemia; diabetes, ACEi).
  • Metabolic alkalosis - classify by urine chloride: chloride-responsive (low urine Cl⁻ - vomiting, NG suction, previous diuretics; treat with saline) versus chloride-resistant (high urine Cl⁻ - Conn's, Cushing's, Bartter's, Gitelman's, current diuretics).
  • Delta ratio (rise in anion gap ÷ fall in bicarbonate) detects coexisting metabolic processes: <0.4 suggests hyperchloraemic acidosis; 1–2 pure raised-gap acidosis; >2 coexisting metabolic alkalosis.
  • Salicylate poisoning - classic mixed respiratory alkalosis (early, direct respiratory stimulation) and raised-gap metabolic acidosis.
Fluids and Acid–Base at a Glance
ConceptRemember
TBW60% body weight; ⅔ ICF, ⅓ ECF; ¼ of ECF is plasma
Osmolality2Na + glucose + urea; osmolar gap >10 → toxic alcohols
SodiumVolume = total Na; concentration = water balance
Potassium shifts inInsulin, β₂-agonists, alkalosis
CalciumAdjust for albumin; alkalosis lowers ionised Ca
Winter's (kPa)Expected PaCO₂ = 0.2 × HCO₃ + 1.1
Anion gapNa − (Cl + HCO₃); normal 8–12
Normal-gap acidosisDiarrhoea, RTA, saline, acetazolamide, Addison's
Worked Examples
  • ABG 1: pH 7.21, PaCO₂ 3.1 kPa, HCO₃⁻ 10, Na⁺ 138, Cl⁻ 100 → metabolic acidosis; anion gap 138 − 110 = 28 (raised); expected PaCO₂ = 0.2 × 10 + 1.1 = 3.1 kPa → appropriate compensation. Consider DKA, lactate, toxins, renal failure.
  • ABG 2: pH 7.31, PaCO₂ 8.4 kPa, HCO₃⁻ 34 → respiratory acidosis with metabolic compensation (raised bicarbonate) → acute-on-chronic type 2 respiratory failure (e.g. COPD exacerbation).
  • ABG 3: pH 7.52, PaCO₂ 6.3, HCO₃⁻ 38, K⁺ 2.8, Cl⁻ 85 → metabolic alkalosis with respiratory compensation - persistent vomiting or diuretics (hypokalaemic hypochloraemic).
  • Osmolar gap: Na 140, glucose 5, urea 5 → calculated 290; measured 330 → gap 40 → consider methanol or ethylene glycol (or ethanol) - check levels; fomepizole if toxic alcohol suspected.
  • Fluid distribution: 1 L of 0.9% saline → about 750 mL interstitial, 250 mL plasma; 1 L of 5% glucose → about 670 mL ICF, 250 mL interstitial, 80 mL plasma.
Exam-style Scenarios
  • Scenario. A 25-year-old with severe diarrhoea has pH 7.28, HCO₃⁻ 14, Na⁺ 136, Cl⁻ 112, K⁺ 3.0. What is the acid–base disorder?
    Answer: Normal anion gap metabolic acidosis (136 − 126 = 10) from bicarbonate loss in stool, with hypokalaemia.
  • Scenario. An 80-year-old on bendroflumethiazide is confused with Na⁺ 118 mmol/L that developed over 2 weeks. How fast can it be corrected?
    Answer: Chronic hyponatraemia - aim for no more than 10 mmol/L in 24 hours (8 if high risk) to avoid osmotic demyelination; give hypertonic saline only if severe symptoms (seizures, reduced consciousness), with close sodium monitoring. Stop the thiazide.
  • Scenario. A patient after thyroidectomy reports tingling around the mouth and has a positive Trousseau's sign. Which hormone deficiency is likely, and what bloods would you expect?
    Answer: Hypoparathyroidism (parathyroid damage or removal) - low calcium, high phosphate, low PTH. Check magnesium (hypomagnesaemia impairs PTH secretion).
Key Points
  • Two-thirds of body water is intracellular; 5% glucose distributes through all compartments, saline only through the ECF.
  • Sodium concentration reflects water balance; total sodium reflects volume.
  • Potassium shifts with insulin, β₂-agonists and pH; check magnesium in refractory hypokalaemia or hypocalcaemia.
  • Interpret every ABG in the same order: oxygenation, pH, primary process, compensation, anion gap.
  • Compensation never overcorrects; a normal pH with abnormal CO₂ and HCO₃⁻ suggests a mixed disorder.
Guidelines and Further Reading
  • NICE CG174: Intravenous fluid therapy in adults in hospital
  • European Society of Endocrinology: Clinical practice guideline on hyponatraemia (2014); Society for Endocrinology emergency guidance
  • UK Kidney Association: Management of hyperkalaemia in adults (updated July 2026)
  • Ganong's Review of Medical Physiology; Guyton and Hall Textbook of Medical Physiology
  • Woodrow P. Arterial blood gas analysis (Nursing Standard) - systematic approach

Cellular physiology, tissues and homeostasis

🧬 Cells, tissues, body fluids and homeostasis — page 1 of the Anatomy and Physiology chapter. Almost all disease is a failure of a cell, a tissue or a control system. Understanding how cells keep their internal environment, how fluid moves between compartments and how the body defends its pH and temperature explains oedema, hyponatraemia, acidosis, hyperkalaemia and fever — the bread and butter of clinical medicine.
Your four questions for every physiology topic: What is normal — and what keeps it there? Which sensor, control centre and effector are involved? What happens when the system fails (too much, too little)? How does this explain the patient's signs, results and treatment?


Cell Structure and Organelles
  • The human body contains about 30–40 trillion cells of over 200 types; each (except red cells) has a nucleus, cytoplasm and organelles enclosed by a plasma membrane.
  • Organelles:
    OrganelleFunctionClinical link
    NucleusContains DNA (chromatin); transcription of RNA; nucleolus makes ribosomesNuclear changes in cancer (large nuclei, mitoses)
    MitochondriaATP production (oxidative phosphorylation); own DNA (maternal inheritance); apoptosisMitochondrial disorders (MELAS); cyanide and CO block the respiratory chain
    Rough endoplasmic reticulumProtein synthesis for export and membranes (ribosomes attached)Abundant in plasma cells and pancreatic acinar cells
    Smooth endoplasmic reticulumLipid and steroid synthesis; drug metabolism (cytochrome P450); calcium storage (sarcoplasmic reticulum in muscle)Enzyme induction (rifampicin, carbamazepine)
    Golgi apparatusModifies, packages and sorts proteins (glycosylation)I-cell disease (faulty lysosomal targeting)
    LysosomesAcid hydrolases digest worn-out material and engulfed particlesLysosomal storage diseases (Gaucher, Tay–Sachs, Fabry)
    PeroxisomesFatty acid oxidation (very long chain), hydrogen peroxide breakdownZellweger syndrome, adrenoleukodystrophy
    CytoskeletonMicrofilaments (actin), intermediate filaments, microtubules (cell division, transport, cilia)Colchicine and vinca alkaloids act on microtubules; primary ciliary dyskinesia
    RibosomesTranslate mRNA into proteinTarget of antibiotics (bacterial 70S — macrolides, tetracyclines, aminoglycosides)
  • From gene to protein — DNA → (transcription) → mRNA → (translation at ribosomes) → protein → (folding, modification in ER and Golgi).
  • Cell junctions — tight junctions (seal epithelia — blood–brain barrier), adherens junctions and desmosomes (attach cells — pemphigus targets desmosomes), hemidesmosomes (attach to the basement membrane — bullous pemphigoid), gap junctions (direct electrical and chemical communication — heart muscle).
The Cell Membrane and Transport
  • Structure — phospholipid bilayer (hydrophilic heads outside, hydrophobic tails inside) with cholesterol (stiffness) and proteins (channels, carriers, receptors, enzymes) — the "fluid mosaic" model; glycocalyx on the outer surface.
  • What crosses easily — small, lipid-soluble molecules (O2, CO2, steroids, alcohol, many drugs); water crosses via aquaporins; ions and large polar molecules need proteins.
  • Types of transport:
    TypeHow it worksExamples
    Simple diffusionDown a concentration gradient; no energyO2, CO2 in the lung
    Facilitated diffusionDown a gradient via a carrier or channel; saturableGlucose via GLUT transporters (GLUT4 is insulin-dependent); ion channels
    Primary active transportAgainst a gradient using ATPNa+/K+-ATPase (3 Na+ out, 2 K+ in); H+/K+-ATPase (stomach — PPIs); Ca2+-ATPase
    Secondary active transportUses the Na+ gradient made by the Na+/K+-ATPaseSGLT (glucose with Na+ — gut and kidney; SGLT2 inhibitors); Na+/Ca2+ exchanger; NKCC2 (loop diuretics)
    OsmosisWater moves to the side with more soluteCell swelling in hyponatraemia
    Endocytosis and exocytosisVesicles take in or release large moleculesLDL uptake (receptor-mediated); hormone and neurotransmitter release
  • Na+/K+-ATPase — uses about a quarter of resting energy; keeps intracellular K+ high and Na+ low; inhibited by digoxin; stimulated by insulin and beta-2 agonists (which is why they treat hyperkalaemia).
  • Oral rehydration solution works because glucose–sodium co-transport (SGLT1) pulls water into gut cells even in secretory diarrhoea (cholera).
  • Channelopathies — cystic fibrosis (CFTR chloride channel), long QT syndromes (K+ and Na+ channels), some epilepsies, periodic paralyses.
Resting Membrane Potential
  • Resting membrane potential — the inside of a cell is negative compared with the outside — about –70 mV in neurons and –90 mV in skeletal and cardiac muscle.
  • Why:
    • The Na+/K+-ATPase sets up gradients — K+ high inside (about 140 mmol/L vs 4 outside), Na+ high outside (about 140 vs 10 inside).
    • At rest the membrane is mainly permeable to K+ (leak channels) — K+ diffuses out, leaving negative charge (proteins) inside.
    • The resting potential is therefore close to the potassium equilibrium potential (about –90 mV) — calculated with the Nernst equation; the Goldman equation includes all permeable ions.
  • Ion distribution:
    IonOutside (mmol/L)Inside (mmol/L)Equilibrium potential
    Na+14010–15About +60 mV
    K+4140About –90 mV
    Cl–1055–10About –70 mV
    Ca2+ (free)1.20.0001About +120 mV
  • Clinical consequences of potassium:
    • Hyperkalaemia — smaller K+ gradient → resting potential less negative (partially depolarised) → sodium channels inactivate → reduced excitability — peaked T waves, broad QRS, bradycardia, VF or asystole; calcium gluconate stabilises the membrane (raises threshold).
    • Hypokalaemia — hyperpolarisation and delayed repolarisation — muscle weakness, ileus, U waves, arrhythmias (especially with digoxin).
  • Calcium and excitability — low extracellular calcium increases nerve excitability (lower threshold) — tetany, perioral tingling, Chvostek's and Trousseau's signs; high calcium reduces excitability (weakness, constipation, confusion).
Cell Signalling and Receptors
  • Types of signalling — endocrine (hormones in blood), paracrine (to neighbouring cells — prostaglandins), autocrine (to itself — IL-2), neural (neurotransmitters across synapses), juxtacrine (direct contact).
  • Receptor families:
    ReceptorMechanism and speedExamples
    Ligand-gated ion channelOpens a channel — millisecondsNicotinic ACh receptor (neuromuscular junction), GABA-A (benzodiazepines), NMDA, 5-HT3 (ondansetron)
    G protein-coupled receptor (GPCR)Activates G proteins and second messengers — secondsAdrenoceptors, muscarinic, opioid, dopamine, histamine, angiotensin II, PTH, glucagon receptors — the largest drug target family
    Enzyme-linked (tyrosine kinase)Receptor phosphorylates proteins — minutesInsulin, growth factors (EGFR, VEGF); tyrosine kinase inhibitors (imatinib); JAK–STAT (cytokines — JAK inhibitors)
    Nuclear (intracellular) receptorLipid-soluble ligand alters gene transcription — hours to daysSteroids (cortisol, aldosterone, oestrogen), thyroid hormone, vitamin D, retinoids
  • G proteins and second messengers:
    • Gs — ↑ adenylyl cyclase → ↑ cAMP → protein kinase A (β-receptors, glucagon, TSH, PTH, ADH V2).
    • Gi — ↓ cAMP (α2, M2, opioid, D2).
    • Gq — ↑ phospholipase C → IP3 (releases intracellular Ca2+) and DAG (protein kinase C) (α1, M1 and M3, H1, angiotensin II AT1, V1).
    • Disease — cholera toxin (permanently activates Gs → watery diarrhoea), pertussis toxin (blocks Gi), McCune–Albright (activating Gs mutation).
  • Agonists and antagonists — agonists activate receptors (efficacy and potency); antagonists block (competitive — surmountable; non-competitive); partial agonists (buprenorphine) produce a submaximal response.
  • Receptor regulation — down-regulation with prolonged stimulation (tolerance — beta-agonists, opioids); up-regulation with blockade (rebound tachycardia when beta-blockers stop suddenly).
The Cell Cycle, Growth and Cell Death
  • Cell cycle — G1 (growth) → S (DNA synthesis) → G2 (preparation) → M (mitosis) — G0 is a resting state; checkpoints (G1/S — p53 and Rb; G2/M) stop damaged cells dividing.
  • Cell types by dividing ability:
    • Labile — divide continuously — skin, gut lining, bone marrow (affected by chemotherapy — mucositis, hair loss, neutropenia).
    • Stable — normally quiescent, can divide when needed — liver, kidney tubules, fibroblasts.
    • Permanent — can't divide — neurons, cardiac muscle, (most) skeletal muscle — heal by scarring.
  • Mitosis (two identical diploid cells) vs meiosis (four haploid gametes; crossing over; non-disjunction causes trisomies) — see the Genetics chapter.
  • Cellular adaptations:
    • Hypertrophy — bigger cells (left ventricle in hypertension; skeletal muscle with exercise).
    • Hyperplasia — more cells (endometrium, prostate, thyroid in Graves').
    • Atrophy — smaller cells (disuse, denervation, ischaemia, ageing).
    • Metaplasia — one mature cell type replaced by another (Barrett's oesophagus — squamous to columnar; bronchial squamous metaplasia in smokers) — can progress to dysplasia.
    • Dysplasia — disordered growth with atypical cells (cervical CIN) — precancerous.
  • Cell death:
    ApoptosisNecrosis
    NatureProgrammed, energy-dependent ("cell suicide")Uncontrolled death from injury
    FeaturesCell shrinks, nuclear fragmentation, apoptotic bodies; no inflammationCell swells and bursts; inflammation
    TriggersDevelopment, DNA damage (p53), cytotoxic T cells, withdrawal of growth factors; caspases and Bcl-2 familyIschaemia, toxins, infection, trauma
    ExamplesShaping fingers in the embryo; failure → cancer (Bcl-2 in follicular lymphoma — venetoclax)Coagulative (MI), liquefactive (brain, abscess), caseous (TB), fat (pancreatitis), fibrinoid (vasculitis), gangrene
  • Healing — regeneration (labile and stable tissue with an intact framework) or repair by scarring (fibrosis) — inflammation → granulation tissue → remodelling.
The Four Basic Tissues
TissueFeaturesExamples
EpitheliumSheets of cells on a basement membrane; covers surfaces and lines cavities; avascular; forms glandsSkin epidermis, gut lining, kidney tubules, alveoli
Connective tissueCells within an extracellular matrix (fibres and ground substance); supports and connectsBone, cartilage, tendons, fat, blood, dermis
MuscleContractile cells (actin and myosin)Skeletal, cardiac, smooth
Nervous tissueNeurons (conduct signals) and glia (support)Brain, spinal cord, peripheral nerves
  • Types of muscle:
    SkeletalCardiacSmooth
    AppearanceStriated, multinucleate, long fibresStriated, branched, 1–2 central nuclei, intercalated discsNon-striated, spindle-shaped, 1 nucleus
    ControlVoluntary (somatic nerves)Involuntary — intrinsic pacemaker, autonomic modulationInvoluntary — autonomic, hormones, stretch
    Ca2+ sourceSarcoplasmic reticulum; troponinExtracellular entry triggers SR release ("calcium-induced calcium release"); troponinExtracellular and SR; calmodulin and myosin light-chain kinase
    RegenerationLimited (satellite cells)Very limited — scar after MIGood
  • Glial cells — astrocytes (support, blood–brain barrier, scar — gliosis; astrocytoma), oligodendrocytes (myelin in the CNS — multiple sclerosis), Schwann cells (myelin in the PNS — Guillain–Barré; schwannoma), microglia (immune cells of the CNS), ependymal cells (line ventricles; CSF).
Epithelium and Glands
  • Classification — by number of layers (simple — one layer; stratified — several; pseudostratified — one layer that looks layered) and cell shape (squamous, cuboidal, columnar).
  • Types and locations:
    EpitheliumWhereFunction
    Simple squamousAlveoli, capillaries (endothelium), serosa (mesothelium)Diffusion, filtration
    Simple cuboidalKidney tubules, thyroid follicles, small ductsSecretion, absorption
    Simple columnarStomach, intestine (with microvilli and goblet cells), gallbladderAbsorption, secretion
    Pseudostratified ciliated columnar ("respiratory epithelium")Nasal cavity, trachea, bronchiMucociliary clearance
    Stratified squamous (keratinised)SkinProtection, waterproofing
    Stratified squamous (non-keratinised)Mouth, oesophagus, vagina, cornea, ectocervixProtection from abrasion
    Transitional (urothelium)Renal pelvis, ureters, bladder, proximal urethraStretch; barrier to urine
  • Transition zones are where cancers often start — squamocolumnar junction of the cervix (HPV), gastro-oesophageal junction (Barrett's), anorectal junction.
  • Cancer naming — epithelial cancers are carcinomas (squamous cell carcinoma, adenocarcinoma from glands, urothelial carcinoma); connective tissue cancers are sarcomas.
  • Glands:
    • Exocrine — secrete through ducts (salivary, sweat, pancreatic acini, breast).
    • Endocrine — ductless, secrete into blood (thyroid, adrenal, islets).
    • Secretion types — merocrine (exocytosis — most), apocrine (part of the cell — axillary sweat, breast), holocrine (whole cell — sebaceous glands).
  • Basement membrane — type IV collagen and laminin; invasion through it distinguishes invasive cancer from carcinoma in situ; antibodies against it — Goodpasture's (anti-GBM); Alport syndrome (type IV collagen mutation).
Connective Tissue, Cartilage and Bone
  • Components — cells (fibroblasts, adipocytes, macrophages, mast cells) and extracellular matrix — fibres (collagen, elastin, reticulin) and ground substance (proteoglycans, glycosaminoglycans, water).
  • Collagen — the body's main structural protein (triple helix; needs vitamin C for hydroxylation — scurvy):
    • Type I — bone, tendon, skin, scar (late) — osteogenesis imperfecta.
    • Type II — cartilage, vitreous.
    • Type III — blood vessels, early scar, skin — vascular Ehlers–Danlos.
    • Type IV — basement membranes — Alport, Goodpasture.
  • Elastin — recoil in arteries, lungs and skin (fibrillin scaffold — Marfan syndrome; elastin breakdown in emphysema — alpha-1 antitrypsin deficiency).
  • Adipose tissue — white fat (energy store, endocrine — leptin, adiponectin) and brown fat (heat production — infants).
  • Cartilage — avascular (heals poorly):
    • Hyaline — articular surfaces, costal cartilage, trachea, growth plates (osteoarthritis — loss of hyaline cartilage).
    • Fibrocartilage — intervertebral discs, menisci, pubic symphysis.
    • Elastic — ear, epiglottis.
  • Bone:
    • Cortical (compact) — outer shell, osteons (Haversian systems) — 80% of bone mass.
    • Trabecular (cancellous) — inner spongy bone; metabolically active — vertebrae, femoral neck and distal radius (osteoporotic fracture sites).
    • Cells — osteoblasts (build bone — alkaline phosphatase), osteocytes (mechanosensors — sclerostin), osteoclasts (resorb bone — from monocytes; activated by RANKL — denosumab blocks it; bisphosphonates inhibit them).
    • Ossification — endochondral (cartilage model replaced by bone — long bones, growth plates — achondroplasia) and intramembranous (skull vault, clavicle — cleidocranial dysplasia).
    • Remodelling — continuous; about 10% of the skeleton is replaced each year; controlled by PTH, vitamin D, calcitonin, oestrogen (menopause → bone loss), mechanical loading.
  • Fracture healing — haematoma → inflammation → soft callus (cartilage) → hard callus (woven bone) → remodelling (lamellar bone) — slowed by smoking, diabetes, steroids, NSAIDs (possibly), poor blood supply (scaphoid, femoral neck, tibia).
Homeostasis and Feedback
  • Homeostasis — keeping the internal environment (temperature, pH, glucose, blood pressure, osmolality, oxygen) within narrow limits (Claude Bernard's "milieu intérieur"; Cannon).
  • Components of a control system — sensor (receptor) → control centre (integrator — often the hypothalamus or brainstem) → effector → response.
  • Negative feedback (most systems) — the response opposes the change:
    • Blood pressure — baroreceptors (carotid sinus, aortic arch) → medulla → heart rate and vascular tone.
    • Blood glucose — insulin and glucagon.
    • Osmolality — hypothalamic osmoreceptors → ADH and thirst.
    • Hormone axes — hypothalamus → pituitary → target gland (e.g. cortisol suppresses CRH and ACTH — the basis of suppression tests; long-term steroids suppress the adrenals).
  • Positive feedback (amplifies the change — usually to complete an event) — oxytocin in labour (Ferguson reflex), the LH surge before ovulation, blood clotting cascade, action potential upstroke (sodium channels).
  • Feedforward — anticipatory responses (salivation before eating; increased breathing at the start of exercise).
  • Disease as failed homeostasis — diabetes (glucose), hypertension (BP), heart failure (neurohormonal activation becomes harmful), shock (compensatory mechanisms overwhelmed).
  • Normal ranges — defined as the central 95% of a healthy population — so 1 in 20 healthy people have a "normal" value outside the range; age, sex, pregnancy and ethnicity matter.
Body Fluid Compartments
  • Total body water (TBW) — about 60% of body weight in adult men (about 42 L in a 70 kg man), 50–55% in women (more fat), 75% in term infants, and less in older people and obesity (fat contains little water).
  • Distribution ("60–40–20"):
    CompartmentFractionVolume (70 kg)Main ions
    Intracellular fluid (ICF)Two-thirds of TBW (40% of body weight)About 28 LK+, phosphate, proteins, Mg2+
    Extracellular fluid (ECF)One-third of TBW (20% of body weight)About 14 LNa+, Cl–, HCO3–
    — Interstitial fluidThree-quarters of ECFAbout 10.5 LAs plasma, little protein
    — PlasmaOne-quarter of ECFAbout 3.5 LNa+, Cl–, proteins (albumin)
    — TranscellularSmallAbout 1 LCSF, synovial, pleural, GI secretions
  • Blood volume — about 70 mL/kg in adults (about 5 L) and 80 mL/kg in children.
  • Where IV fluids go:
    • 0.9% saline or Hartmann's (isotonic, sodium-containing) — stays in the ECF — only about a quarter stays in plasma (1 L raises plasma volume by about 250 mL).
    • 5% glucose — glucose is metabolised, leaving free water that spreads through all of TBW — only about 1/12 stays in plasma — useless for resuscitation; risk of hyponatraemia.
    • Colloids and blood — initially stay mainly in plasma.
  • Osmolality — normal plasma osmolality 275–295 mOsm/kg; calculated osmolality = 2 × Na+ + glucose + urea; osmolar gap (measured – calculated) over 10 suggests unmeasured osmoles (methanol, ethylene glycol, ethanol, mannitol).
  • Sodium and water — sodium content determines ECF volume (aldosterone, natriuretic peptides); water balance determines sodium concentration (ADH, thirst) — hyponatraemia is usually a water problem.
  • Daily water balance (adult) — intake about 2.5 L (drink 1.5 L, food 0.8 L, metabolic water 0.3 L); output — urine 1.5 L, insensible losses (skin and lungs) about 0.8 L, faeces 0.1–0.2 L; insensible losses rise with fever (about 10% per °C) and tachypnoea.
Capillary Exchange and Oedema
  • Starling forces govern fluid movement across capillary walls:
    • Hydrostatic pressure in the capillary (pushes fluid out) — higher at the arterial end.
    • Oncotic (colloid osmotic) pressure of plasma proteins — mainly albumin (pulls fluid in).
    • Interstitial hydrostatic and oncotic pressures (small).
    • Capillary permeability (reflection coefficient).
  • Net filtration occurs along most capillaries; about 90% is reabsorbed and the rest (about 2–4 L a day) returns via the lymphatics (current understanding — the "revised Starling principle" and the endothelial glycocalyx mean little reabsorption happens in most capillaries, making lymph flow even more important).
  • Causes of oedema:
    MechanismExamples
    Raised capillary hydrostatic pressureHeart failure, fluid overload, venous obstruction (DVT), calcium channel blockers (arteriolar dilatation — ankle oedema), pregnancy
    Low plasma oncotic pressure (low albumin)Nephrotic syndrome, liver cirrhosis, malnutrition (kwashiorkor), protein-losing enteropathy
    Increased permeabilityInflammation, sepsis (capillary leak), burns, anaphylaxis, ARDS
    Lymphatic obstructionLymphoedema — after axillary node clearance or radiotherapy, filariasis, congenital (Milroy) — non-pitting with time
  • Pitting vs non-pitting — pitting (fluid displaced by pressure — most causes); non-pitting (lymphoedema, pretibial myxoedema, lipoedema).
  • Pulmonary oedema — raised left atrial pressure (cardiogenic) or increased permeability (ARDS — non-cardiogenic).
  • Effusions and ascites — fluid in serous cavities; transudates (pressure or protein problems) vs exudates (inflammation, malignancy — high protein, Light's criteria).
Acid–base Physiology
  • Normal arterial pH 7.35–7.45 ([H+] about 40 nmol/L); the body produces about 15,000 mmol of CO2 (volatile acid) and 50–100 mmol of non-volatile (fixed) acid a day.
  • Three lines of defence:
    • Buffers (seconds) — bicarbonate (main extracellular buffer), haemoglobin, proteins, phosphate (intracellular and urine), bone.
    • Lungs (minutes to hours) — change CO2 excretion by altering ventilation (central and peripheral chemoreceptors).
    • Kidneys (hours to days) — reabsorb filtered bicarbonate (proximal tubule), generate new bicarbonate and excrete H+ as ammonium and titratable acid (phosphate) (distal tubule).
  • The bicarbonate buffer system — CO2 + H2O ⇌ H2CO3 ⇌ H+ + HCO3– (carbonic anhydrase speeds the first step).
  • Henderson–Hasselbalch equation — pH = 6.1 + log ([HCO3–] ÷ (0.23 × PaCO2 in kPa)) — pH depends on the ratio of bicarbonate (kidney) to CO2 (lung).
  • Four primary disorders and compensation:
    DisorderPrimary changeCompensationExample
    Metabolic acidosis↓ HCO3–↓ CO2 (hyperventilation — Kussmaul)DKA, lactic acidosis, AKI
    Metabolic alkalosis↑ HCO3–↑ CO2 (hypoventilation — limited)Vomiting, diuretics
    Respiratory acidosis↑ CO2↑ HCO3– (renal — days)COPD, opioid overdose
    Respiratory alkalosis↓ CO2↓ HCO3– (renal)Anxiety, PE, altitude
  • Acid–base and potassium — acidosis shifts K+ out of cells (hyperkalaemia); alkalosis shifts K+ into cells (hypokalaemia) — and hypokalaemia itself maintains metabolic alkalosis.
  • Acid–base and calcium — alkalosis increases binding of calcium to albumin → lower ionised calcium → tingling and tetany in hyperventilation.
  • Full blood gas interpretation and anion gap — see the Critical Care and Acute Medicine chapters.
Energy Metabolism
  • ATP — the cell's energy currency; produced by:
    • Glycolysis (cytoplasm) — glucose → 2 pyruvate + 2 ATP; without oxygen, pyruvate → lactate (anaerobic — shock, exercise, red cells have no mitochondria).
    • Krebs (citric acid) cycle (mitochondria) — acetyl-CoA → CO2, NADH, FADH2; pyruvate dehydrogenase needs thiamine (deficiency → lactic acidosis, Wernicke's).
    • Oxidative phosphorylation (electron transport chain) — about 30–32 ATP per glucose; needs oxygen; blocked by cyanide and CO; uncoupled by salicylates (heat).
  • Fed state (insulin dominant) — glucose uptake (muscle and fat — GLUT4), glycogen synthesis, fat storage (lipogenesis), protein synthesis; insulin also drives K+, phosphate and magnesium into cells (refeeding syndrome).
  • Fasting state (glucagon, cortisol, adrenaline, growth hormone):
    • Glycogenolysis (liver) — first 12–24 hours.
    • Gluconeogenesis (liver and kidney) — from lactate (Cori cycle), amino acids (alanine) and glycerol.
    • Lipolysis → fatty acids → ketone bodies (liver) — the brain adapts to use ketones in prolonged starvation.
    • Ketoacidosis happens when insulin is absent (DKA) — unrestrained lipolysis and ketogenesis; alcohol and starvation ketoacidosis.
  • Glucose-dependent tissues — brain (mostly), red cells, renal medulla, lens.
  • Basal metabolic rate — about 1,400–1,800 kcal a day in adults (about 25 kcal/kg/day); raised by thyroid hormone, fever, sepsis, burns, pregnancy; total energy expenditure adds activity and digestion.
  • Energy content — carbohydrate and protein about 4 kcal/g, fat about 9 kcal/g, alcohol about 7 kcal/g.
Temperature Regulation
  • Normal core temperature — about 37°C (36.5–37.5°C); varies by about 0.5°C over the day (lowest early morning, highest late afternoon); rises after ovulation (progesterone).
  • Control — thermoreceptors in the skin and core → hypothalamus (preoptic area — the thermostat) → effectors.
  • Heat production — basal metabolism, muscle activity, shivering, non-shivering thermogenesis (brown fat — infants; thyroid hormone).
  • Heat loss — radiation, conduction, convection, evaporation (sweating — sympathetic cholinergic fibres — anticholinergic drugs impair it).
  • Responses:
    • Cold — skin vasoconstriction, shivering, piloerection, behaviour.
    • Heat — skin vasodilatation, sweating, behaviour.
  • Fever vs hyperthermia:
    • Fever — the hypothalamic set point is raised by pyrogens (IL-1, IL-6, TNF → prostaglandin E2 in the hypothalamus) — the body feels cold and shivers (rigors) to reach the new set point; antipyretics (paracetamol, NSAIDs) work by reducing PGE2.
    • Hyperthermia — the set point is normal but heat production or gain exceeds loss (heat stroke, MH, NMS, serotonin syndrome, drugs) — antipyretics don't work — physical cooling is needed.
  • Older people — blunted fever response in infection; reduced shivering and thirst; higher risk of hypothermia and heat illness.
  • Environmental heat and cold — see the Emergency Medicine chapter.
Cells and Homeostasis at a Glance
TopicKey facts
Na+/K+-ATPase3 Na+ out, 2 K+ in; digoxin inhibits; insulin and beta-agonists stimulate
Resting potentialAbout –70 to –90 mV; set mainly by K+ permeability
HyperkalaemiaPartial depolarisation; calcium stabilises the membrane
ReceptorsIon channel (ms), GPCR (s), tyrosine kinase (min), nuclear (hours)
G proteinsGs ↑ cAMP; Gi ↓ cAMP; Gq → IP3/Ca2+
MetaplasiaOne mature cell type replaced by another — Barrett's
Apoptosis vs necrosisProgrammed, no inflammation vs uncontrolled, inflammation
Respiratory epitheliumPseudostratified ciliated columnar
CollagenI bone/skin, II cartilage, III vessels, IV basement membrane
OsteoclastsResorb bone; RANKL; bisphosphonates and denosumab
Total body water60% of weight; ICF 2/3, ECF 1/3; plasma 1/4 of ECF
Saline vs 5% glucoseSaline stays in ECF; glucose spreads through all body water
Osmolality2 × Na + glucose + urea; normal 275–295
Oedema↑ hydrostatic, ↓ oncotic, ↑ permeability, lymphatic block
Acid–base defenceBuffers (seconds), lungs (minutes), kidneys (days)
FeverRaised set point (PGE2) — antipyretics work; hyperthermia — they don't
Spot the Diagnosis
ClueDiagnosis or mechanism
Nausea, yellow vision and hyperkalaemia in an older woman on a cardiac drugDigoxin toxicity — Na+/K+-ATPase inhibition
Peaked T waves and broad QRS; K+ 7.4Hyperkalaemia — give calcium to stabilise the membrane
Perioral tingling and carpopedal spasm after hyperventilatingRespiratory alkalosis — reduced ionised calcium
Profuse watery diarrhoea after travel to an area with poor sanitationCholera — toxin activates Gs (cAMP)
Columnar epithelium with goblet cells in the lower oesophagusBarrett's oesophagus (intestinal metaplasia)
Bleeding gums, perifollicular haemorrhages and poor wound healingScurvy — vitamin C (collagen hydroxylation)
Blue sclerae and multiple fractures in a childOsteogenesis imperfecta (type I collagen)
Tall, long fingers, lens dislocation and aortic root dilatationMarfan syndrome (fibrillin-1)
Arterial rupture and thin translucent skin in a young adultVascular Ehlers–Danlos (type III collagen)
Haematuria, deafness and eye problems in a young manAlport syndrome (type IV collagen)
Ankle swelling after starting amlodipineRaised capillary hydrostatic pressure
Generalised oedema with albumin 18 and heavy proteinuriaNephrotic syndrome — low oncotic pressure
Arm swelling 2 years after axillary clearance for breast cancerLymphoedema
Osmolar gap of 30 in a confused man with acidosisToxic alcohol (methanol or ethylene glycol)
Hypophosphataemia and heart failure after starting feeds in a malnourished patientRefeeding syndrome (insulin drives ions into cells)
Rigors with temperature 39.5°C in pneumoniaFever — raised hypothalamic set point
Exam-style Scenarios

1. A 70-year-old man on the ward has a potassium of 7.1 mmol/L with peaked T waves and widened QRS complexes.
Answer: Severe hyperkalaemia — explain the physiology of treatment.

  • Calcium gluconate — doesn't lower potassium; restores the gap between resting potential and threshold (membrane stabilisation).
  • Insulin with glucose and salbutamol — stimulate the Na+/K+-ATPase to shift K+ into cells (temporary).
  • Remove K+ from the body — stop causes, potassium binders, dialysis if needed.

2. A 50 kg woman needs IV fluids. A colleague suggests 1 L of 5% glucose to treat her hypotension.
Answer: Wrong fluid for resuscitation.

  • 5% glucose becomes free water and spreads through all body water — less than 100 mL of each litre stays in plasma.
  • Use an isotonic crystalloid (Hartmann's or 0.9% saline) — stays in the ECF; about a quarter remains intravascular.
  • Large volumes of hypotonic fluid risk hyponatraemia, especially after surgery (high ADH).

3. A 6-year-old has periorbital and leg oedema, frothy urine and serum albumin of 15 g/L.
Answer: Nephrotic syndrome (likely minimal change disease).

  • Oedema from reduced plasma oncotic pressure (and sodium retention by the kidney).
  • Other consequences — hyperlipidaemia, infection risk (immunoglobulin loss), thrombosis (antithrombin loss).
  • Treatment — steroids; manage fluid and sodium.

4. A 20-year-old with type 1 diabetes has pH 7.12, bicarbonate 8 mmol/L and PaCO2 2.8 kPa. She is breathing deeply and rapidly.
Answer: Metabolic acidosis (DKA) with respiratory compensation.

  • Lack of insulin → lipolysis → ketone bodies (fixed acids) consume bicarbonate.
  • Kussmaul breathing — chemoreceptors drive hyperventilation to lower CO2.
  • Potassium shifts out of cells (total body K+ is low) — insulin will drive it back in, so replace potassium.

5. A 30-year-old man has a temperature of 41°C after a festival where he took ecstasy. Paracetamol hasn't helped.
Answer: Drug-induced hyperthermia, not fever.

  • The hypothalamic set point is normal; heat production exceeds loss (muscle activity, serotonergic and sympathetic effects).
  • Antipyretics don't work — need active cooling, benzodiazepines, fluids.
  • Watch for hyponatraemia (MDMA increases ADH and water intake), rhabdomyolysis, DIC.
Key Points
  • The Na+/K+-ATPase maintains ion gradients — digoxin blocks it; insulin and beta-agonists stimulate it.
  • Resting membrane potential depends mainly on potassium — explaining the dangers of hyper- and hypokalaemia.
  • Know the four receptor families and G protein second messengers — they explain most drug actions.
  • Labile cells are hit by chemotherapy; permanent cells (neurons, heart) heal by scar.
  • Metaplasia and dysplasia are steps towards cancer at transition zones.
  • Learn collagen types and their diseases.
  • Total body water is 60% of weight — two-thirds intracellular; 5% glucose spreads through all of it.
  • Oedema — raised hydrostatic pressure, low oncotic pressure, leaky capillaries or blocked lymphatics.
  • pH depends on the bicarbonate:CO2 ratio — buffers, lungs and kidneys defend it.
  • Insulin drives glucose, potassium and phosphate into cells — refeeding syndrome and hyperkalaemia treatment.
  • Fever raises the set point (antipyretics work); hyperthermia doesn't (cooling needed).
Guidelines and Further Reading
  • Guyton and Hall: Textbook of Medical Physiology
  • Ganong's Review of Medical Physiology
  • Wheater's Functional Histology
  • Robbins and Cotran: Pathologic Basis of Disease (cell injury, adaptation and death)
  • Rang and Dale's Pharmacology (receptors and signalling)
  • NICE CG174: Intravenous fluid therapy in adults in hospital
  • Medical Schools Council: Medical Licensing Assessment (MLA) content map — applied basic sciences
  • BNF — for current doses
End of chapter 211